CheckRx Raises $750,000 Pre‑seed Round

Why It Matters

CheckRx tackles Medicare’s opacity, potentially lowering costs for millions of seniors while disrupting the broker‑centric model that drives inflated premiums.

Key Takeaways

• CheckRx automates Medicare plan comparison, saving agents ~950 hours annually
• Platform offers seniors free AI or human‑assisted plan selection
• Raised $750k pre‑seed; declined $12M acquisition at age 19
• Founder’s youth philanthropy raised $3.3M for health and education
• AI leverages CMS data to make Medicare more transparent

Pulse Analysis

The United States Medicare system, serving over 65 million beneficiaries, has long been criticized for its labyrinthine plan structures and opaque pricing. Seniors often rely on insurance brokers who are incentivized to steer them toward higher‑margin products, inflating overall costs by billions each year. Emerging artificial‑intelligence tools are beginning to pierce this veil, offering data‑driven clarity that could reshape how public health insurance is navigated and priced.

CheckRx exemplifies this shift. By ingesting Centers for Medicare & Medicaid Services (CMS) data and applying natural‑language processing, the platform delivers instant, side‑by‑side plan comparisons and automates routine administrative tasks. Agents report saving roughly 950 hours annually, freeing them to focus on personalized counseling rather than paperwork. For seniors, the service is free and available through either a fully automated AI flow or a hybrid human‑assisted experience, ensuring accessibility across tech‑savvy and less‑digitally inclined users alike. Early adoption stories highlight substantial out‑of‑pocket savings and even ancillary benefits such as grocery stipends embedded in newer plan designs.

Holm’s venture also signals a broader trend of Gen Z founders leveraging deep personal experience to address entrenched industry pain points. The $750,000 pre‑seed infusion, coupled with a bold refusal of a $12 million buyout, underscores investor confidence in scalable, mission‑driven health‑tech solutions. As regulators contemplate greater transparency mandates for Medicare, platforms like CheckRx could become indispensable intermediaries, potentially prompting a re‑evaluation of broker compensation structures and accelerating the shift toward a more consumer‑centric, data‑transparent healthcare marketplace.

Deal Summary

San Diego‑based AI‑native Medicare platform CheckRx announced the closing of a $750,000 pre‑seed round to expand its AI‑driven plan comparison and member retention tools for seniors. The funding will support further development of its platform that automates Medicare workflow and improves transparency for seniors. The round was disclosed in a profile of founder Augustus Holm, published May 7, 2026.